Salih Şanlıoğlu
Impact in
- Genetics top 2%
- Virus-based gene therapy research
- Diabetes and associated disorders
- Immunology top 5%
Papers in
-
- Cell death mechanisms and regulation 16
- RNA Interference and Gene Delivery 10
- CRISPR and Genetic Engineering 10
- Genetics 23
- Virus-based gene therapy research 15
- Diabetes and associated disorders 9
- Co-authors
- John F. Engelhardt (12 shared papers)Ahter Dilşad Şanlioğlu (35 shared papers)Thomas S. Griffith (22 shared papers)Mustafa Kemal Balcı (14 shared papers)Gary W. Hunninghake (5 shared papers)Peter K Benson (3 shared papers)Lobelia Samavati (2 shared papers)Hasan Altunbaş (7 shared papers)
- Journals
- Human Gene Therapy (6 papers)Cancer Gene Therapy (4 papers)Expert Reviews in Molecular Medicine (3 papers)Gene Therapy (3 papers)BMC Cancer (3 papers)
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
Salih Şanlıoğlu
70 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 105
- Genetics 795
- Immunology 459
- Molecular Biology 1.5k
- Cancer Research 279
- Developmental Neuroscience 76
Countries citing papers authored by Salih Şanlıoğlu
This map shows the geographic impact of Salih Şanlıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salih Şanlıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salih Şanlıoğlu more than expected).
Fields of papers citing papers by Salih Şanlıoğlu
This network shows the impact of papers produced by Salih Şanlıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salih Şanlıoğlu. The network helps show where Salih Şanlıoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Salih Şanlıoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 369 | |
| 2 | 2000 | 213 | |
| 3 | 1994 | 168 | |
| 4 | 2005 | 112 | |
| 5 | 2013 | 99 | |
| 6 | 2002 | 96 | |
| 7 | 1999 | 78 | |
| 8 | 2001 | 77 | |
| 9 | 2001 | 74 | |
| 10 | 1998 | 69 | |
| 11 | 1999 | 68 | |
| 12 | 1999 | 55 | |
| 13 | 2004 | 54 | |
| 14 | 2004 | 53 | |
| 15 | 2000 | 53 | |
| 16 | 2003 | 47 | |
| 17 | 2013 | 46 | |
| 18 | 2007 | 41 | |
| 19 | 2012 | 39 | |
| 20 | 2005 | 39 |
About Salih Şanlıoğlu
Salih Şanlıoğlu is a scholar working on Molecular Biology, Genetics, Immunology, Surgery and Cancer Research, having authored 74 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (16 papers), Pancreatic function and diabetes (15 papers), Virus-based gene therapy research (15 papers), RNA Interference and Gene Delivery (10 papers), CRISPR and Genetic Engineering (10 papers), Diabetes and associated disorders (9 papers), Immune Response and Inflammation (7 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Genetics (795 citations), Immunology (459 citations), Molecular Biology (1.5k citations), Cancer Research (279 citations) and Developmental Neuroscience (76 citations). Salih Şanlıoğlu has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include John F. Engelhardt, Ahter Dilşad Şanlioğlu, Thomas S. Griffith, Mustafa Kemal Balcı, Gary W. Hunninghake, Peter K Benson, Lobelia Samavati, Hasan Altunbaş, Bahri Karaçay and Jusan Yang. Their work appears in journals such as Human Gene Therapy, Cancer Gene Therapy, Expert Reviews in Molecular Medicine, Gene Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.